Literature DB >> 20153303

Proposed mode of action of benzene-induced leukemia: Interpreting available data and identifying critical data gaps for risk assessment.

M E Bette Meek1, James E Klaunig.   

Abstract

Mode of action is defined as a series of key biological events leading to an observed toxicological effect (for example, metabolism to a toxic entity, cell death, regenerative repair and tumors). It contrasts with mechanism of action, which generally involves a detailed understanding of the molecular basis for an effect. A framework to consider the weight of evidence for hypothesized modes of action in animals and their relevance to humans, has been widely adopted and used by government agencies and international organizations. The framework, developed and refined through its application in case studies for principally non-DNA-reactive carcinogens, has more recently been extended to DNA-reactive carcinogens, non-cancer endpoints and different life stages. In addition to increasing transparency, use of the framework promotes consistency in decision-making concerning adequacy of weight of evidence, facilitates peer input and review and identifies critical research needs. The framework provides an effective tool to facilitate discussion between the research and risk assessment communities on critical data gaps, which if filled, would permit more refined estimates of risk. As a basis for additionally coordinating and focusing research on critical data gaps in a risk assessment context, five key events in the mode of action for benzene-induced leukemia are proposed: (1) benzene metabolism via Cytochrome P450, (2) the interaction of benzene metabolites with target cells in the bone marrow, (3) formation of initiated, mutated target cells, (4) selective proliferation of the mutated cells and (5) production of leukemia. These key events are considered in a framework analysis of human relevance as a basis to consider appropriate next steps in developing research strategies. Crown Copyright (c) 2010. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153303     DOI: 10.1016/j.cbi.2010.02.006

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  14 in total

Review 1.  Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment.

Authors:  Cliona M McHale; Luoping Zhang; Martyn T Smith
Journal:  Carcinogenesis       Date:  2011-12-12       Impact factor: 4.944

Review 2.  The use of biomonitoring data in exposure and human health risk assessment: benzene case study.

Authors:  Scott M Arnold; Juergen Angerer; Peter J Boogaard; Michael F Hughes; Raegan B O'Lone; Steven H Robison; A Robert Schnatter
Journal:  Crit Rev Toxicol       Date:  2013-02       Impact factor: 5.635

3.  Technical guide for applications of gene expression profiling in human health risk assessment of environmental chemicals.

Authors:  Julie A Bourdon-Lacombe; Ivy D Moffat; Michelle Deveau; Mainul Husain; Scott Auerbach; Daniel Krewski; Russell S Thomas; Pierre R Bushel; Andrew Williams; Carole L Yauk
Journal:  Regul Toxicol Pharmacol       Date:  2015-05-02       Impact factor: 3.271

4.  Benzene, the exposome and future investigations of leukemia etiology.

Authors:  Martyn T Smith; Luoping Zhang; Cliona M McHale; Christine F Skibola; Stephen M Rappaport
Journal:  Chem Biol Interact       Date:  2011-02-17       Impact factor: 5.192

Review 5.  Putative adverse outcome pathways relevant to neurotoxicity.

Authors:  Anna Bal-Price; Kevin M Crofton; Magdalini Sachana; Timothy J Shafer; Mamta Behl; Anna Forsby; Alan Hargreaves; Brigitte Landesmann; Pamela J Lein; Jochem Louisse; Florianne Monnet-Tschudi; Alicia Paini; Alexandra Rolaki; André Schrattenholz; Cristina Suñol; Christoph van Thriel; Maurice Whelan; Ellen Fritsche
Journal:  Crit Rev Toxicol       Date:  2015-01       Impact factor: 5.635

Review 6.  Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans.

Authors:  Chad M Thompson; Deborah M Proctor; Mina Suh; Laurie C Haws; Christopher R Kirman; Mark A Harris
Journal:  Crit Rev Toxicol       Date:  2013-03       Impact factor: 5.635

Review 7.  Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity.

Authors:  Anna Bal-Price; Pamela J Lein; Kimberly P Keil; Sunjay Sethi; Timothy Shafer; Marta Barenys; Ellen Fritsche; Magdalini Sachana; M E Bette Meek
Journal:  Neurotoxicology       Date:  2016-05-17       Impact factor: 4.294

Review 8.  Epigenetic Effects of Benzene in Hematologic Neoplasms: The Altered Gene Expression.

Authors:  Giovanna Spatari; Alessandro Allegra; Mariella Carrieri; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

Review 9.  Advancing human health risk assessment: integrating recent advisory committee recommendations.

Authors:  Michael Dourson; Richard A Becker; Lynne T Haber; Lynn H Pottenger; Tiffany Bredfeldt; Penelope A Fenner-Crisp
Journal:  Crit Rev Toxicol       Date:  2013-07       Impact factor: 5.635

Review 10.  Mode of action human relevance (species concordance) framework: Evolution of the Bradford Hill considerations and comparative analysis of weight of evidence.

Authors:  M E Bette Meek; Christine M Palermo; Ammie N Bachman; Colin M North; R Jeffrey Lewis
Journal:  J Appl Toxicol       Date:  2014-02-10       Impact factor: 3.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.